The IGF-1/IGFBP-3 complex has been shown to exert anti-apoptotic effects on small intestinal epithelial cells [29,30,31,32,33], and lower IGFBP-3 levels have been associated with disease activity in inflammatory bowel disease [29,30]. Here, IGF1 is linked to inflammatory bowel disease.